secwatch.observer — SEC 8-K summary
======================================

Issuer:     Polaryx Therapeutics, Inc. (PLYX)
CIK:        0002075320
Form:       8-K
Filed at:   2026-09-11T23:59:23+00:00
Accession:  0001213900-26-099416
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Polaryx shareholders re-elect Alex Yang, Mitchel Berger as Class I directors
----------------------------------------------------------------------------

- Alex Yang and Mitchel Berger re-elected as Class I directors at Sept 10, 2026 annual meeting.
- Each director received 30,072,137 votes for, 332 withheld, with 472,610 broker non-votes.
- Ratification of Grant Thorton LLP as auditor for FY2026 approved: 30,510,106 for, 34,973 against.
- Directors will serve until the 2029 annual meeting of stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2075320/000121390026099416/0001213900-26-099416-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2075320/000121390026099416/ea0305352-8k_polaryx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-099416

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer